Arçelik (ARCLK) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Full year 2024 revenues reached TRY 458.5 billion, up 15% year-on-year, mainly from European and MENA acquisitions, while local sales were flat and international sales grew 24.7% in inflation-adjusted terms.
Gross margin declined to 27.6% from 29.3% year-on-year due to pricing pressures, competition, unfavorable EUR/USD parity, and higher manufacturing costs.
Adjusted EBITDA margin was 5.3%, down from 8.2% last year, impacted by higher OPEX and lower gross profitability.
Net loss of TRY 2.2 billion reported for 2024, with a net margin of -0.5%, reflecting a 6.1 point decline year-on-year.
Major restructuring and integration activities, including plant closures in the UK and planned closures in Poland and Italy, are underway, with related costs fully provisioned in 2024.
Financial highlights
Consolidated revenues grew 15% year-on-year; Q4 revenues declined 5% sequentially.
Gross margin fell by 1.8 points year-on-year; Q4 margin improved 0.5 points over the previous quarter.
Operating profit dropped 66% year-on-year to TRY 5.7 billion; operating margin dropped 3.2 points year-on-year.
Adjusted EBITDA for 2024 was TRY 22.9 billion, down 25% year-on-year, with one-off transaction expenses excluded.
Free cash flow was negative TRY 18.1 billion, down from negative TRY 8.7 billion in 2023.
Outlook and guidance
2025 guidance targets 15% international revenue growth in EUR terms and local revenue growth in real terms.
EBITDA margin expected to improve to around 6.5% in 2025, driven by cost synergies and operational efficiencies.
Net working capital to sales ratio expected to fall below 20% by year-end 2025.
Capex guidance for 2025 is approximately EUR 300 million, mainly for maintenance and new product investments.
Cost savings of EUR 100-150 million expected in 2025 from restructuring and synergies.
Latest events from Arçelik
- Revenue fell and a net loss was posted, but cash flow and profitability improved in tough markets.ARCLK
Q4 202516 Feb 2026 - Revenue surged after acquisitions, but margins and net income fell amid higher costs.ARCLK
Q2 20242 Feb 2026 - Revenue up 14% YoY, but margins and net income declined amid integration and cost pressures.ARCLK
Q3 202418 Jan 2026 - Revenue and profit fell, but margins improved and 2025 guidance was maintained.ARCLK
Q2 20256 Jan 2026 - Q3 revenue dropped 11.4% y/y, but margins improved amid restructuring and acquisitions.ARCLK
Q3 202514 Dec 2025 - Sales up 9.3% y/y, but net loss and margin pressure amid restructuring and inflation.ARCLK
Q1 202529 Nov 2025